 | • レポートコード：MRC2305A041 • 出版社/出版日：Transparency Market Research / 2023年3月29日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トランスパレンシーマーケットリサーチ社の市場調査資料では、世界のIn Vivo毒物学市場規模が、2023年の52億ドルから2033年に95億ドルとなり、予測期間中にCAGR 5.6%で拡大すると見込んでいます。本資料は、In Vivo毒物学の世界市場について市場実態を明らかにし、将来を展望したレポートであり、エグゼクティブサマリー、市場概要、市場背景、製品別（器具、消耗品）分析、検査別（急性、亜急性、亜慢性、慢性検査）分析、検査施設別（外部委託検査施設、インハウス検査施設）分析、毒性エンドポイント別（免疫毒性、全身毒性、発がん性、遺伝毒性、その他）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。本書内には、Charles River Laboratories,、THE JACKSON LABORATORY、Envigo、Taconic Biosciences, Inc.、genOway、Thermo Fisher Scientific、Danaher Corporation、Waters Corporation、Agilent Technologies、Shimadzu Corporation、Bruker Corporation、PerkinElmer、Merck KGaA、BioSpace、Bio-Rad Laboratoriesなどの企業情報を含んでいます。 ・エグゼクティブサマリー ・市場概要 ・市場背景 ・世界のIn Vivo毒物学市場規模：製品別 - 器具の市場規模 - 消耗品の市場規模 ・世界のIn Vivo毒物学市場規模：検査別 - 急性検査の市場規模 - 亜急性検査の市場規模 - 亜慢性検査の市場規模 - 慢性検査の市場規模 ・世界のIn Vivo毒物学市場規模：検査施設別 - 外部委託検査施設における市場規模 - インハウス検査施設における市場規模 ・世界のIn Vivo毒物学市場規模：毒性エンドポイント別 - 免疫毒性検査の市場規模 - 全身毒性検査の市場規模 - 発がん性検査の市場規模 - 遺伝毒性検査の市場規模 - その他毒性エンドポイントの市場規模 ・世界のIn Vivo毒物学市場規模：地域別 - 北米のIn Vivo毒物学市場規模 - 中南米のIn Vivo毒物学市場規模 - ヨーロッパのIn Vivo毒物学市場規模 - アジア太平洋のIn Vivo毒物学市場規模 - 中東・アフリカのIn Vivo毒物学市場規模 ・市場構造分析 ・競争分析 ・仮定 ・調査手法 |
In Vivo Toxicology Market – Scope of Report
TMR’s report on the global in vivo toxicology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global in vivo toxicology market for the period 2017–2033, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global in vivo toxicology market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the in vivo toxicology market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global in vivo toxicology market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global in vivo toxicology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global in vivo toxicology market.
The report delves into the competitive landscape of the global in vivo toxicology market. Key players operating in the global in vivo toxicology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global in vivo toxicology market profiled in this report.
Key Questions Answered in Global In Vivo Toxicology Market Report
• What is the sales/revenue generated by in vivo toxicology across all regions during the forecast period?
• What are the opportunities in the global in vivo toxicology market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2033?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
In Vivo Toxicology Market – Research Objectives and Research Approach
The comprehensive report on the global in vivo toxicology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global in vivo toxicology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2033 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global in vivo toxicology market.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018-2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023-2033
5.3.1. Instruments
5.3.2. Consumables
5.3.2.1. Reagents & Kits
5.3.2.2. Animal Models
5.4. Y-o-Y Growth Trend Analysis By Product, 2018-2022
5.5. Absolute $ Opportunity Analysis By Product, 2023-2033
6. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Test Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018-2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023-2033
6.3.1. Acute
6.3.2. Sub-acute
6.3.3. Sub-chronic
6.3.4. Chronic Test Type
6.4. Y-o-Y Growth Trend Analysis By Test Type, 2018-2022
6.5. Absolute $ Opportunity Analysis By Test Type, 2023-2033
7. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Testing Facility
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Testing Facility , 2018-2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Testing Facility , 2023-2033
7.3.1. Outsourced Testing Facility
7.3.2. In-house Testing Facility
7.4. Y-o-Y Growth Trend Analysis By Testing Facility , 2018-2022
7.5. Absolute $ Opportunity Analysis By Testing Facility , 2023-2033
8. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Toxicity End Point
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By Toxicity End Point, 2018-2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Toxicity End Point, 2023-2033
8.3.1. Immunotoxicity
8.3.2. Systemic Toxicity
8.3.3. Carcinogenicity
8.3.4. Genotoxicity
8.3.5. Developmental & Reproductive Toxicity
8.3.6. Other Toxicity End Points
8.4. Y-o-Y Growth Trend Analysis By Toxicity End Point, 2018-2022
8.5. Absolute $ Opportunity Analysis By Toxicity End Point, 2023-2033
9. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By End User
9.1. Introduction / Key Findings
9.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018-2022
9.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023-2033
9.3.1. Academic and Research Institutes
9.3.2. Pharmaceutical & Biotechnology Companies
9.3.3. Contract Research Organizations
9.3.4. Others
9.4. Y-o-Y Growth Trend Analysis By End User, 2018-2022
9.5. Absolute $ Opportunity Analysis By End User, 2023-2033
10. Global In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Region
10.1. Introduction
10.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018-2022
10.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023-2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. U.S.
11.2.1.2. Canada
11.2.2. By Product
11.2.3. By Test Type
11.2.4. By Testing Facility
11.2.5. By Toxicity End Point
11.2.6. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Test Type
11.3.4. By Testing Facility
11.3.5. By Toxicity End Point
11.3.6. By End User
11.4. Key Takeaways
12. Latin America In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. Brazil
12.2.1.2. Mexico
12.2.1.3. Rest of Latin America
12.2.2. By Product
12.2.3. By Test Type
12.2.4. By Testing Facility
12.2.5. By Toxicity End Point
12.2.6. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Test Type
12.3.4. By Testing Facility
12.3.5. By Toxicity End Point
12.3.6. By End User
12.4. Key Takeaways
13. Europe In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
13.2.1. By Country
13.2.1.1. U.K.
13.2.1.2. Spain
13.2.1.3. Germany
13.2.1.4. Italy
13.2.1.5. France
13.2.1.6. Rest of Europe
13.2.2. By Product
13.2.3. By Test Type
13.2.4. By Testing Facility
13.2.5. By Toxicity End Point
13.2.6. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Test Type
13.3.4. By Testing Facility
13.3.5. By Toxicity End Point
13.3.6. By End User
13.4. Key Takeaways
14. Asia Pacific In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. India
14.2.1.4. Rest of Asia Pacific
14.2.2. By Product
14.2.3. By Test Type
14.2.4. By Testing Facility
14.2.5. By Toxicity End Point
14.2.6. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Test Type
14.3.4. By Testing Facility
14.3.5. By Toxicity End Point
14.3.6. By End User
14.4. Key Takeaways
15. Middle East and Africa In Vivo Toxicology Market Analysis 2018-2022 and Forecast 2023-2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018-2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023-2033
15.2.1. By Country
15.2.1.1. South Africa
15.2.1.2. GCC Countries
15.2.1.3. Rest of Middle East and Africa
15.2.2. By Product
15.2.3. By Test Type
15.2.4. By Testing Facility
15.2.5. By Toxicity End Point
15.2.6. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Test Type
15.3.4. By Testing Facility
15.3.5. By Toxicity End Point
15.3.6. By End User
15.4. Key Takeaways
16. Key Countries In Vivo Toxicology Market Analysis
16.1. U.S.
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Test Type
16.1.2.3. By Testing Facility
16.1.2.4. By Toxicity End Point
16.1.2.5. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Test Type
16.2.2.3. By Testing Facility
16.2.2.4. By Toxicity End Point
16.2.2.5. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Test Type
16.3.2.3. By Testing Facility
16.3.2.4. By Toxicity End Point
16.3.2.5. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Test Type
16.4.2.3. By Testing Facility
16.4.2.4. By Toxicity End Point
16.4.2.5. By End User
16.5. U.K.
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Test Type
16.5.2.3. By Testing Facility
16.5.2.4. By Toxicity End Point
16.5.2.5. By End User
16.6. Spain
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Test Type
16.6.2.3. By Testing Facility
16.6.2.4. By Toxicity End Point
16.6.2.5. By End User
16.7. Germany
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Test Type
16.7.2.3. By Testing Facility
16.7.2.4. By Toxicity End Point
16.7.2.5. By End User
16.8. Italy
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Test Type
16.8.2.3. By Testing Facility
16.8.2.4. By Toxicity End Point
16.8.2.5. By End User
16.9. France
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Test Type
16.9.2.3. By Testing Facility
16.9.2.4. By Toxicity End Point
16.9.2.5. By End User
16.10. China
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Test Type
16.10.2.3. By Testing Facility
16.10.2.4. By Toxicity End Point
16.10.2.5. By End User
16.11. Japan
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Test Type
16.11.2.3. By Testing Facility
16.11.2.4. By Toxicity End Point
16.11.2.5. By End User
16.12. India
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Test Type
16.12.2.3. By Testing Facility
16.12.2.4. By Toxicity End Point
16.12.2.5. By End User
16.13. South Africa
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Test Type
16.13.2.3. By Testing Facility
16.13.2.4. By Toxicity End Point
16.13.2.5. By End User
16.14. GCC Countries
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Test Type
16.14.2.3. By Testing Facility
16.14.2.4. By Toxicity End Point
16.14.2.5. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Test Type
17.3.4. By Testing Facility
17.3.5. By Toxicity End Point
17.3.6. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Charles River Laboratories
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. THE JACKSON LABORATORY
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Envigo
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Taconic Biosciences, Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. genOway
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Thermo Fisher Scientific
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Danaher Corporation
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Waters Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Agilent Technologies
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Shimadzu Corporation
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Bruker Corporation
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. PerkinElmer
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
18.1.13. Merck KGaA
18.1.13.1. Overview
18.1.13.2. Product Portfolio
18.1.13.3. Profitability by Market Segments
18.1.13.4. Sales Footprint
18.1.13.5. Strategy Overview
18.1.13.5.1. Marketing Strategy
18.1.14. BioSpace
18.1.14.1. Overview
18.1.14.2. Product Portfolio
18.1.14.3. Profitability by Market Segments
18.1.14.4. Sales Footprint
18.1.14.5. Strategy Overview
18.1.14.5.1. Marketing Strategy
18.1.15. Bio-Rad Laboratories
18.1.15.1. Overview
18.1.15.2. Product Portfolio
18.1.15.3. Profitability by Market Segments
18.1.15.4. Sales Footprint
18.1.15.5. Strategy Overview
18.1.15.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Table 1: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Region, 2018-2033
Table 2: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 3: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 4: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 5: Global In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 6: Global In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 7: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 8: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 9: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 10: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 11: North America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 12: North America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 13: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 14: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 15: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 16: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 17: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 18: Latin America In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 19: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 20: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 21: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 22: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 23: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 24: Europe In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 25: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 26: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 27: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 28: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 29: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 30: Asia Pacific In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033
Table 31: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Country, 2018-2033
Table 32: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Product, 2018-2033
Table 33: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Test Type, 2018-2033
Table 34: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Testing Facility , 2018-2033
Table 35: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by Toxicity End Point, 2018-2033
Table 36: Middle East and Africa In Vivo Toxicology Market Value (US$ Million) Forecast by End User, 2018-2033